Chemoradiation in patients with unresectable extrahepatic and hilar cholangiocarcinoma or at high risk for disease recurrence after resection : Analysis of treatment efficacy and failure in patients receiving postoperative or primary chemoradiation.

MLA

Habermehl D, et al. “Chemoradiation in Patients with Unresectable Extrahepatic and Hilar Cholangiocarcinoma or at High Risk for Disease Recurrence after Resection : Analysis of Treatment Efficacy and Failure in Patients Receiving Postoperative or Primary Chemoradiation.” Strahlentherapie Und Onkologie, vol. 188, no. 9, Sept. 2012, pp. 795–801. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=104444778&authtype=sso&custid=ns315887.

APA

Habermehl D, Lindel K, Rieken S, Haase K, Goeppert B, Büchler MW, Schirmacher P, Welzel T, Debus J, Combs SE, Habermehl, D., Lindel, K., Rieken, S., Haase, K., Goeppert, B., Büchler, M. W., Schirmacher, P., Welzel, T., Debus, J., & Combs, S. E. (2012). Chemoradiation in patients with unresectable extrahepatic and hilar cholangiocarcinoma or at high risk for disease recurrence after resection : Analysis of treatment efficacy and failure in patients receiving postoperative or primary chemoradiation. Strahlentherapie Und Onkologie, 188(9), 795–801.

Chicago

Habermehl D, Lindel K, Rieken S, Haase K, Goeppert B, Büchler MW, Schirmacher P, et al. 2012. “Chemoradiation in Patients with Unresectable Extrahepatic and Hilar Cholangiocarcinoma or at High Risk for Disease Recurrence after Resection : Analysis of Treatment Efficacy and Failure in Patients Receiving Postoperative or Primary Chemoradiation.” Strahlentherapie Und Onkologie 188 (9): 795–801. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=104444778&authtype=sso&custid=ns315887.